| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/07/2007 | CA2632181A1 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 06/07/2007 | CA2631931A1 Cancer therapies and pharmaceutical compositions used therein |
| 06/07/2007 | CA2631746A1 Urea compounds useful in the treatment of cancer |
| 06/07/2007 | CA2631292A1 Derivatised wt1 cancer antigen peptides and their use |
| 06/07/2007 | CA2630884A1 Inhibitors of c-met and uses thereof |
| 06/07/2007 | CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 06/07/2007 | CA2630164A1 3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as ephb and vegfr2 kinase inhibitors |
| 06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
| 06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
| 06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
| 06/06/2007 | EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent |
| 06/06/2007 | EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes |
| 06/06/2007 | EP1792898A1 Molecular chaperone function regulator |
| 06/06/2007 | EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 06/06/2007 | EP1792622A1 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues |
| 06/06/2007 | EP1792613A2 Dicationic compounds which selectively recognize G-quadruplex DNA |
| 06/06/2007 | EP1792610A2 Sustained release bioadhesive therapeutic systems |
| 06/06/2007 | EP1791959A2 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 06/06/2007 | EP1791865A2 Cells expressing a modified t cell receptor |
| 06/06/2007 | EP1791864A2 Methods of using death receptor ligands and cd20 antibodies |
| 06/06/2007 | EP1791837A1 Substituted hydantoins for the treatment of cancer |
| 06/06/2007 | EP1791836A1 Thiazolinone 2-substituted quinolines |
| 06/06/2007 | EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791539A1 Process to prepare camptothecin derivatives |
| 06/06/2007 | EP1578438B1 Synthetic peptide analogs for the treatment of cancer |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | EP1423108B1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1363874B1 Tryptase inhibitors |
| 06/06/2007 | EP1363601B1 Amphoteric liposomes and the use thereof |
| 06/06/2007 | EP1333866A4 Polymer based radionuclide containing particulate material |
| 06/06/2007 | EP1333865A4 Inorganic low density radionuclide coated particles |
| 06/06/2007 | EP1333864A4 Low density radionuclide-containing particulate material |
| 06/06/2007 | EP1289556B1 Isoflavones against radiation-induced mortality |
| 06/06/2007 | EP1272211B1 Methods and compositions for treating neoplasms |
| 06/06/2007 | EP1230378B1 An oncolytic adenovirus |
| 06/06/2007 | EP1229922B1 Aplidine treatment of cancers |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | EP0956017B1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer |
| 06/06/2007 | EP0939824B1 Reagents and methods useful for detecting diseases of the breast |
| 06/06/2007 | EP0920446B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/06/2007 | DE102005057924A1 Pyridazinonderivate Pyridazinone derivatives |
| 06/06/2007 | CN1976951A Anti-EpCAM immunoglobulins |
| 06/06/2007 | CN1976936A Tetrahydroquinolines |
| 06/06/2007 | CN1976931A Beta-carbolines useful for treating inflammatory disease |
| 06/06/2007 | CN1976927A Quinoline thiazolinone compound |
| 06/06/2007 | CN1976925A Prodrugs of pyrrolylpyrimidine ERK protein kinase inhibitors |
| 06/06/2007 | CN1976721A Method to reduce hepatotoxicity of FAS-mediated apoptosis-inducing agents |
| 06/06/2007 | CN1976698A 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations |
| 06/06/2007 | CN1974759A Attenuated salmonella transporting recombinant plasmid and its application in treating tumor |
| 06/06/2007 | CN1974598A Isolated proteins from a traditional Chinese medicine yuzhu and use thereof |
| 06/06/2007 | CN1974576A N1,N8-disubstituent-triethyl tetramine copper (II) complex and its prepn process |
| 06/06/2007 | CN1974570A Fused pyrrolocarbazoles against inflammation |
| 06/06/2007 | CN1974554A Cyclin imide peptidyl metalloprotease inhibitor and its application |
| 06/06/2007 | CN1973902A Anticancer medicine adriamycin composition with ginseng polyse as carrier and its prepn process |
| 06/06/2007 | CN1973899A Immunomodulator for treating malignant tumor |
| 06/06/2007 | CN1973888A Process of extracting rutin and other flavone matters from asparagus |
| 06/06/2007 | CN1973883A Tumor-treating oral Chinese medicine composition |
| 06/06/2007 | CN1973879A Anticancer medicine and its prepn |
| 06/06/2007 | CN1973859A Cancer treating Chinese medicine prepn |
| 06/06/2007 | CN1973852A Medicine composition containing matrine and astragaloside and its use |
| 06/06/2007 | CN1973843A Degradable polymer supported nanometer Daunorubicin microsphere and its prepn process |
| 06/06/2007 | CN1973834A Application of curcumin in preparing medicine for inventing drug resistance of malignant tumor |
| 06/06/2007 | CN1973829A Process of preparing calcitonin microsphere |
| 06/06/2007 | CN1973826A Injection containing lipoid microsphere of etoposide and its prepn process |
| 06/06/2007 | CN1973824A Anticancer composition containing both platinum compound and Sirolimus |
| 06/06/2007 | CN1973823A Anticancer composition containing Synergist |
| 06/06/2007 | CN1973822A Anticancer composition containing Sirolimus |
| 06/06/2007 | CN1973821A Medicine composition containing both anticancer medicine and its synergist |
| 06/06/2007 | CN1973820A Anticancer composition containing Sirolimus and its application |
| 06/06/2007 | CN1973819A Anticancer composition containing anticancer medicine and its synergist |
| 06/06/2007 | CN1973818A Solid tumor treating medicine composition |
| 06/06/2007 | CN1973817A Solid tumor treating slow releasing prepn containing chemotherapy synergist |
| 06/06/2007 | CN1973687A Health oyster-turtle powder |
| 06/06/2007 | CN1320114C Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody and its application |
| 06/06/2007 | CN1319991C Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/06/2007 | CN1319983C An polyspike acid ester as antitumor active component and its preparation process and use |
| 06/06/2007 | CN1319975C Camptothecin analogs and methods of preparation thereof |
| 06/06/2007 | CN1319971C Camptothecine derivatives and their use |
| 06/06/2007 | CN1319970C Camptothecin derivative used as anti-tumor agent and preparation method thereof |
| 06/06/2007 | CN1319966C Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/06/2007 | CN1319963C Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/06/2007 | CN1319961C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 06/06/2007 | CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/06/2007 | CN1319957C Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 06/06/2007 | CN1319950C 3-substituted-4-pyrimidone derivatives |
| 06/06/2007 | CN1319933C Compound essence of Dothiorella and its preparation method and uses |
| 06/06/2007 | CN1319583C Medicine for treating lung cancer and preparing process thereof |
| 06/06/2007 | CN1319553C Chinese traditional medicine for external application for treating primary liver cancer and cirrhosis of liver |
| 06/06/2007 | CN1319534C Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 06/06/2007 | CN1319525C Taxinol-sodium alginate micro ball vascular embolism agent and its preparation |
| 06/06/2007 | CN1319524C Turmeria oil extract dripping pill, its preparation method and application |
| 06/06/2007 | CN1319522C Method for preparing cinobufotalin lyophilized powder |
| 06/06/2007 | CA2630357A1 Pyrimidine-2,4-diamines and their uses |
| 06/05/2007 | USRE39682 Enzyme inhibitors, for cancer therapy |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |